Comparison of the effects of thymosin and other thymic factors on modulation of interleukin-2 production.
Zatz. M M MM; Oliver. J J; Sztein. M B MB; Skotnicki. A B AB; Goldstein. A L AL
Key Findings
- TF5 enhances IL‑2 production by human peripheral blood mononuclear cells when stimulated with PHA.
- The IL‑2‑boosting effect is not due to thymosin‑alpha‑1 or thymosin‑beta‑4, the two previously characterized peptides in TF5.
- The active component is still unidentified and appears unique to TF5 and a similar porcine thymus extract.
Practical Outcomes
- For biohackers, this means thymosin‑alpha‑1 probably won’t increase IL‑2 levels, so it isn’t a useful stand‑alone immune‑boosting supplement based on this data. No dosage or protocol can be recommended, and further research is needed to pinpoint the active factor.
Summary
The study found that a thymus extract (TF5) can boost a key immune signal (IL‑2) in lab‑grown human blood cells, but this boost isn’t caused by the well‑known peptide thymosin‑alpha‑1. The real active ingredient is still unknown, so the result doesn’t give a clear way to use thymosin‑alpha‑1 for health benefits.
Abstract
Thymosin fraction 5 (TF5) enhances interleukin-2 (IL-2) production by human peripheral blood mononuclear leukocytes (PBL) when cocultured in the presence of phytohemagglutinin (PHA). This important biological activity of TF5 is not due to the presence of two previously well-characterized component peptides, thymosin alpha 1 and thymosin beta 4, but rather to a new, still to be identified component of TF5. Comparison of TF5 with other well-defined thymic preparations and peptides indicates that this biological activity is unique to TF5 and a closely related extract prepared from porcine thymus tissue. Using a standard human PBL cell population obtained by leukopheresis and cryopreservation, it should now be possible to establish a reproducible bioassay for the isolation and characterization of one or more components of TF5 with the property of enhancing PHA-induced IL-2 production by human PBL.
Study Information
pubmed
1985